Promising combo therapy for uterine cancer shows potential, but trial halted early
NCT ID NCT05481645
First seen Jan 10, 2026 · Last updated May 24, 2026 · Updated 15 times
Summary
This study tested a new drug (TQB2450) combined with chemotherapy, with or without another drug (anlotinib), as a first treatment for advanced endometrial cancer or uterine sarcoma. The goal was to see if the combination could shrink tumors. The trial was terminated early, but data from 71 participants may still provide insights. Participants received the drugs and were monitored for tumor response and side effects.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ADVANCED ENDOMETRIAL CANCER are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
Hunan Cancer Hospital
Changsha, Hunan, 410013, China
-
Liaoning Cancer Hospital & Institute
Shenyang, Liaoning, 110801, China
-
Linyi Cancer Hospital
Linyi, Shandong, 276002, China
-
Obstetrics & Gynecology Hospital of Fudan University
Shanghai, Shanghai Municipality, 200090, China
-
Shandong Cancer Hospital
Jinan, Shandong, 250117, China
-
Sun Yat-sen Memorial Hospital
Guangzhou, Guangdong, 510120, China
-
Taizhou People's Hospital
Taizhou, Jiangsu, 225399, China
-
The First Affiliated Hospital of Xi'an Jiaotong University
Xi'an, Shaanxi, 710061, China
-
TianJin Medical University Cancer Institute & Hopspital
Tianjin, Tianjin Municipality, 300181, China
-
Yantai Yuhuangding Hospital
Yantai, Shandong, 264099, China
-
Zhongnan Hospital of Wuhan University
Wuhan, Hubei, 430062, China
Conditions
Explore the condition pages connected to this study.